Using IHC, we found that IL-1β and IL-18, two pro-inflammatory cytokines activated by the NLRP3 inflammasome, were significantly increased in the AKI condition, while treatment with EVs, pFUS, or both reduced their expression (Figure 3A). Here, NLRP3 is linked to acute kidney injury.